Author： Ozdemir Vural Joly Yann Knoppers Bartha
Publisher： Routledge Ltd
ISSN： 1536-0075
Source： American Journal of Bioethics, Vol.11, Iss.3, 2011-03, pp. : 11-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pharmacogenomics: Role in Medicines Approval and Clinical Use
Public Health Genomics, Vol. 13, Iss. 5, 2009-10 ,pp. :
Access to resources
Recommend
Precautionary Harm Disclosure in Clinical Trials
American Journal of Bioethics, Vol. 9, Iss. 8, 2009-08 ,pp. :
Clinical Application of Pharmacogenomics: The Example of HLA-Based Drug-Induced Toxicity
Public Health Genomics, Vol. 17, Iss. 5-6, 2014-10 ,pp. :
Can Contracts Enhance Participant Autonomy in Clinical Trials?
American Journal of Bioethics, Vol. 11, Iss. 4, 2011-04 ,pp. :
Assessing the Remedy: The Case for Contracts in Clinical Trials
American Journal of Bioethics, Vol. 11, Iss. 4, 2011-04 ,pp. :